Recombinant Chicken AP2A2

• Cat.No.: AP2A2-2111C
• Product Overview: Recombinant Chicken AP2A2 full length or partial length protein was expressed.

Specification

• Source: Mammalian Cells
• Species: Chicken
• Tag: His
• Form: Liquid or lyophilized powder
• Endotoxin: < 1.0 eu per μg of the protein as determined by the LAL method.
• Purity: >80%
• Notes: This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
• Storage: Store it at +4 oC for short term. For long term storage, store it at -20 oC～-80 oC.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: AP2A2 adaptor-related protein complex 2, alpha 2 subunit [ Gallus gallus (chicken) ]
• Official Symbol: AP2A2
• Gene ID: 423102
• Protein Refseq: NP_001012914
• UniProt ID: Q5F3T4

Reviews

04/19/2021

The sensitivity of AP2A2 in Western blot is very high, and low concentrations of the target protein can be detected.

01/18/2020

I appreciate the production process of AP2A2, every step is strictly controlled to ensure the quality and repeatability of the product.

11/25/2019

Under different pH conditions, the stability of this protein is still very good, indicating that it has excellent acid-base stability.

08/21/2019

AP2A2 are structurally stable and not prone to mutation.

Q&As

What is the mechanism of AP2A2 in antitumor therapy?

Recombinant AP2A2 may play an antitumor role by inhibiting tumor growth and promoting autoimmunity.

What are the storage conditions of AP2A2 injection?

Normally, AP2A2 injections should be stored in the refrigerator at a temperature of 2-8 ° C.

By what means can AP2A2 therapy be delivered to patients?

Recombinant AP2A2 therapy can be administered intravenously or intramuscularly.

What are the preparation methods of AP2A2 ?

Generally, the preparation methods of AP2A2 include recombinant DNA technology and protein expression and purification technology.

What is the progress of recombinant AP2A2 in clinical trials?

At present, the recombinant AP2A2 protein is still in clinical trials, and researchers are evaluating its safety and efficacy.

Is there any research showing that recombinant AP2A2 can improve patients' quality of life?

There are no clear studies showing that the AP2A2 improves patients' quality of life, but its therapeutic effect may vary for individuals.

What are the effects of recombinant AP2A2 on the immune system?

Recombinant AP2A2 protein may regulate immune cell activity and enhance immune response, but the specific mechanism still needs to be further studied.

Is there any research showing that recombinant AP2A2 can prevent certain diseases?

While some studies have shown that recombinant AP2A2 has a preventive effect, more research is needed to confirm its effectiveness.

What are the remaining challenges in the research of AP2A2 ?

The study of AP2A2 still faces challenges in terms of safety, efficacy and stability.

Is there any research showing that recombinant AP2A2 is effective in the treatment of autoimmune diseases?

Although some preliminary studies suggest that recombinant AP2A2 may have a therapeutic effect on autoimmune diseases, more clinical trials are needed to determine its efficacy.

How to evaluate the effectiveness of AP2A2 therapy?

Evaluation of the effectiveness of AP2A2 therapy usually includes clinical symptom improvement, biomarker level detection, etc.

Are there side effects of recombinant AP2A2?

No definite side effects have been reported, but please consult your doctor before receiving treatment.

Is AP2A2 therapy suitable for everyone?

The indication for the treatment of AP2A2 needs to be determined based on the specific disease and individual patient situation. Consult your doctor for more accurate advice.

How long is the usual course of treatment for AP2A2 ?

The duration of treatment for AP2A2 varies according to the purpose of treatment and individual differences, please consult your doctor for details.

In what diseases is recombinant AP2A2 used?

Currently, the AP2A2 shows potential in the treatment of certain cancers and autoimmune diseases.

Are there any limitations to the clinical use of recombinant AP2A2?

There is no clear clinical limit to its use, but different diseases and individual conditions may affect its therapeutic effectiveness.

Can recombinant AP2A2 be used to treat other non-immune-related diseases?

There are no clear studies showing that recombinant AP2A2 has a therapeutic effect on non-immune-related diseases.

What is the main function of AP2A2 ?

Recombinant protein AP2A2 is mainly involved in intracellular material transport and endocytosis.

What is the therapeutic effect of recombinant AP2A2 on certain cancers?

Some studies have shown that recombinant AP2A2 can inhibit the growth and spread of certain cancer cells, but further clinical studies are needed to verify its therapeutic effect.